THE ECONOMIC BURDEN OF METASTATIC AND PROSTATE SPECIFIC ANTIGEN PROGRESSION IN PATIENTS WITH PROSTATE CANCER: FINDINGS FROM A RETROSPECTIVE ANALYSIS OF HEALTH PLAN DATA-Reference-Cited by-同舟云学术

THE ECONOMIC BURDEN OF METASTATIC AND PROSTATE SPECIFIC ANTIGEN PROGRESSION IN PATIENTS WITH PROSTATE CANCER: FINDINGS FROM A RETROSPECTIVE ANALYSIS OF HEALTH PLAN DATA

Published:2004-06 Issue:6 Part 1 Volume:171 Page:2250-2254
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

PENSON DAVID F.¹,MOUL JUDD W.¹,EVANS CHRISTOPHER P.¹,DOYLE JOHN J.¹,GANDHI SANJAY¹,LAMERATO LOIS¹

Affiliation:

1. From the Keck School of Medicine, University of Southern California (DFP), Los Angeles, California, Department of Defense Center for Prostate Disease Research (JWM), Rockville, Maryland, University of California-Davis (CPE), Sacramento, California, The Analytica Group (JJD), New York, New York, AstraZeneca (SG), Wilmington, Delaware, and Henry Ford Health System (LL), Detroit, Michigan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

2. An economic overview of prostate carcinoma;Ruchlin;Cancer,2001

3. The economic burden of prostate cancer, California, 1998;Max;Cancer,2002

4. Impact on health service costs of medical technologies used in management of prostatic cancer;Holmberg;Scand J Urol Nephrol,1998

5. Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer;Ciezki;Urology,2000

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The economic impact of disease progression and death in hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer patients: using Korean nationwide health insurance claims data;Current Medical Research and Opinion;2020-10-05

2. Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer;The British Journal of Radiology;2020-10-01

3. Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017;Frontiers in Pharmacology;2020-06-10

4. Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer;Asian Journal of Urology;2017-01

5. Brassinin Combined with Capsaicin Enhances Apoptotic and Anti-metastatic Effects in PC-3 Human Prostate Cancer Cells;Phytotherapy Research;2015-10-01